BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 527341)

  • 1. A comparative study of the effect of the Progestasert TM and Gravigard IUDs on dysmenorrhoea.
    Pizarro E; Gomez-Rogers C; Rowe PJ
    Contraception; 1979 Nov; 20(5):455-66. PubMed ID: 527341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Steroid intra-uterine contraception: progesterone-releasing devices. II. Insertion, clinical problems and contraceptive dependability].
    Custo GM; Cosmi EV
    Patol Clin Ostet Ginecol; 1984; 12(4):331-43. PubMed ID: 12340352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical performance of the TCu 380A and Lippes Loop IUDs in three developing countries.
    Farr G; Amatya R; Acosta M; Ekwempu C; Kisninci H
    Contraception; 1995 Jul; 52(1):17-22. PubMed ID: 8521710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum cortisol level in lactating women using Progestasert system.
    Askalani H; Badraoui MH; Mahrous T; Osman MI; Bayad MA; Ibrahim II; Abdalla MI
    Popul Sci; 1981; (2):109-14. PubMed ID: 12339476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mefenamic acid for dysmenorrhea in patients with intrauterine devices.
    Budoff PW
    JAMA; 1979 Aug; 242(7):616-7. PubMed ID: 448996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum prolactin levels in lactating women using progestasert system.
    Badraoui MH; Askalani H; Mahrous I; Osman MI; Bayad MA; Ibrahim II; Abdalla MT
    Popul Sci; 1981; (2):115-20. PubMed ID: 12339477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Menstrual blood loss and body iron stores: comparative study between a Multiload-375 IUD and a levonorgestrel vaginal ring].
    Souza JP; Andrade AT; Pizarro E
    Bol Cent Biol Reprod; 1991; 10(1):26-32. PubMed ID: 12318141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary report on a postpartum CuT 200 study, Santiago, Chile.
    Lavin P; Waszak C; Bravo C
    Int J Gynaecol Obstet; 1983 Feb; 21(1):71-5. PubMed ID: 6133798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between two IUDs: Progestasert and CuT 200.
    Larsen S; Hansen MK; Jacobsen JC; Ladehoff P; Sorensen T; Westergaard JG
    Contracept Deliv Syst; 1981 Oct; 2(4):281-6. PubMed ID: 12336988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New developments in intrauterine devices.
    Farr G
    Netw Res Triangle Park N C; 1991 Sep; 12(2):9. PubMed ID: 12284281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for copper T IUD expulsion: an epidemiologic analysis.
    Zhang J; Feldblum PJ; Chi IC; Farr MG
    Contraception; 1992 Nov; 46(5):427-33. PubMed ID: 1458889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative studies on menstrual blood loss in IUD users.
    Andrade AT; Pizarro Orchard E
    Contraception; 1987 Jul; 36(1):129-44. PubMed ID: 3311622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of T Cu 200 and Progestasert IUDs.
    Lavin P; Bravo C; Waszak C
    Contracept Deliv Syst; 1983 Apr; 4(2):143-7. PubMed ID: 12338635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A collaborative study of the progesterone intrauterine device (Progestasert). The World Health Organization Task Force on Methods for the Regulation of Implantation.
    Newton J; Szontagh F; Lebech P; Rowe P
    Contraception; 1979 Jun; 19(6):575-89. PubMed ID: 487808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selected events following insertion of the Progestasert system.
    Gibor Y; Mitchell C
    Contraception; 1980 May; 21(5):491-503. PubMed ID: 7428359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of the IUD insertion.
    Edelman DA; Zipper J; Rivera M; Medel M
    Contraception; 1979 May; 19(5):449-54. PubMed ID: 467054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of laparoscopic sterilization and insertion of Multiload Cu 250 and Progestasert IUDs on serum ferritin levels.
    Goh TH; Hariharan M
    Contraception; 1983 Oct; 28(4):329-36. PubMed ID: 6667621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hysterographic orientation of IUDs in relation to menstrual blood loss.
    Kandil O; Aref I; El-sheikha Z; Radwan MM; El-agizi H; Hassanein MK
    Contracept Deliv Syst; 1983 Jul; 4(3):213-7. PubMed ID: 12265365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.